Present-day methicillin-resistant Staphylococcus aureus (MRSA) might have been worse if it had descended directly from a 1950s version of the bug, according to a study co-authored by Barry N. Kreiswirth, PhD, a professor at the Public Health Research Institute of UMDNJ-New Jersey Medical School, and published in the Proceedings of the National Academy of Sciences.
In the early 1950s, a penicillin-resistant version of S. aureus known as phage-type 80/81 emerged in hospitals and quickly spread, causing a decade-long pandemic. The pandemic subsided in the mid-1960s, a few years after the introduction of a new type of antibiotic called methicillin.
By now, however, many bacteria found in hospitals and elsewhere have become resistant to methicillin, and scientists have suspected that these deadly modern MRSA strains descended directly from the 1950s strains. However the bugs DNA tells a different story. Kreiswirth, Frank DeLeo, PhD, of the National Institute of Allergy and Infectious Diseases and colleagues compared the DNA in a total of 284 old and new S. aureus strains and found that the newer strains are not directly descended from the older ones but rather that all evolved from a common ancestor.
Present-day MRSA strains had DNA mutations that rendered them less deadly but more adept at infecting the nasal passages, mutations that were not present in the 1950s strains. These genetic changes make MRSA less deadly in humans but better able to survive and spread, especially in hospital settings where the population has a higher susceptibility to infection than the general population. Had modern MRSA descended directly from phage type 80/81, the authors believe death rates among those infected by MRSA might have been even higher than have been experienced.
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.